Fidelity Investments Portfolio holdings
Fidelity Investments, founded in 1946 by Edward C. Johnson II and headquartered in Boston, Massachusetts, is one of the largest privately-held financial services firms in the world, managing hundreds of billions in assets. Known for its wide array of investment products, including mutual funds, retirement accounts, brokerage services, and wealth management, Fidelity caters to both individual investors and institutions with a reputation for strong customer service and innovative tools like its active trader platforms. The company pioneered direct-to-investor mutual fund sales, bypassing traditional brokers, and has since expanded into areas like cryptocurrency trading and commission-free stock trades. Still family-controlled by the Johnson family, Fidelity blends a legacy of traditional investing with a forward-looking approach to technology and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Medtronic
MDT
|
+$1.83B |
| 2 |
CELG
Celgene Corp
CELG
|
+$1.52B |
| 3 |
UBS Group
UBS
|
+$1.11B |
| 4 |
Johnson & Johnson
JNJ
|
+$920M |
| 5 |
Bank of America
BAC
|
+$919M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$2.98B |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$2.37B |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.33B |
| 4 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$931M |
| 5 |
Coca-Cola
KO
|
+$880M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.24% |
| 2 | Financials | 15.7% |
| 3 | Technology | 13.61% |
| 4 | Consumer Discretionary | 10.27% |
| 5 | Industrials | 9.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
626
Abercrombie & Fitch
ANF
$4.89B
| $223M | 0.03% |
7,785,710
-1,115,752
| -13% | -$34.2M |
|
|
DWA
627
DELISTED
DREAMWORKS ANIMATION SKG INC CL-A
DWA
| $222M | 0.03% |
9,960,954
+2,360,876
| +31% | +$53.4M |
|
|
DISH
628
DELISTED
DISH Network Corp.
DISH
| $222M | 0.03% |
3,048,090
-572,173
| -16% | -$38.5M |
|
|
ENDP
629
DELISTED
Endo International plc
ENDP
| $222M | 0.03% |
3,074,842
-299,453
| -9% | -$20.5M |
|
630
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
$32.8B
| $222M | 0.03% |
1,855,015
+1,250,633
| +207% | +$149M |
|
631
Mohawk Industries
MHK
$9.45B
| $221M | 0.03% |
1,424,340
-191,569
| -12% | -$27.5M |
|
632
Becton Dickinson
BDX
$49.7B
| $221M | 0.03% |
1,629,421
+1,492,234
| +1,088% | +$191M |
|
633
East-West Bancorp
EWBC
$18.6B
| $221M | 0.03% |
5,696,322
-312,228
| -5% | -$11.3M |
|
634
Commault Systems
CVLT
$6.25B
| $220M | 0.03% |
4,257,800
-1,855,188
| -30% | -$89.1M |
|
635
Graphic Packaging
GPK
$3.49B
| $218M | 0.03% |
16,021,375
-3,263,320
| -17% | -$40.4M |
|
|
TMH
636
DELISTED
Team Health Holdings Inc
TMH
| $218M | 0.03% |
3,791,209
+83,789
| +2% | +$4.83M |
|
|
DHC
637
Diversified Healthcare Trust
DHC
$2.02B
| $217M | 0.03% |
9,911,837
+74,111
| +0.8% | +$1.62M |
|
638
CoreCivic
CXW
$3.15B
| $217M | 0.03% |
5,963,676
-986,685
| -14% | -$35.5M |
|
|
CYT
639
DELISTED
CYTEC INDS INC
CYT
| $216M | 0.03% |
4,686,802
-24,980
| -0.5% | -$1.16M |
|
|
CLVS
640
DELISTED
Clovis Oncology, Inc.
CLVS
| $216M | 0.03% |
3,859,599
+183,573
| +5% | +$9.65M |
|
|
ENH
641
DELISTED
Endurance Specialty Holdings Ltd
ENH
| $216M | 0.03% |
3,606,478
-350,000
| -9% | -$20.1M |
|
|
TVPT
642
DELISTED
Travelport Worldwide Limited
TVPT
| $215M | 0.03% |
11,926,548
+4,414,748
| +59% | +$69.1M |
|
|
LLL
643
DELISTED
L3 Technologies, Inc.
LLL
| $214M | 0.03% |
1,696,970
+604,704
| +55% | +$72.3M |
|
|
ASPX
644
DELISTED
AUSPEX PHARMACEUTICALS INC COM STK (DE)
ASPX
| $214M | 0.03% |
4,072,075
+1,452,504
| +55% | +$42.7M |
|
645
DexCom
DXCM
$34.5B
| $213M | 0.03% |
15,444,756
+1,300,340
| +9% | +$15.9M |
|
|
FRC
646
DELISTED
First Republic Bank
FRC
| $212M | 0.03% |
4,059,153
+1,220,000
| +43% | +$61.4M |
|
647
Coty
COTY
$2.44B
| $211M | 0.03% |
10,215,840
-351,681
| -3% | -$6.48M |
|
648
Church & Dwight Co
CHD
$24B
| $211M | 0.03% |
5,353,804
+12,360
| +0.2% | +$457K |
|
|
CTRX
649
DELISTED
CATAMARAN CORP COM STK (CDA)
CTRX
| $211M | 0.03% |
4,072,369
-1,185,733
| -23% | -$55.7M |
|
650
Caesarstone
CSTE
$108M
| $210M | 0.03% |
3,510,284
+669,946
| +24% | +$38.1M |
|
Similar funds
Fidelity Investments's Q4 2014 Portfolio in Review
As of Q4 2014, Fidelity Investments held 2,940 positions worth $769B, up 4.1% from $738B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Fidelity Investments's Q4 2014 filing shows 176 new, 1,100 increased, 1,140 reduced and 160 closed positions. Its largest new stake was UBS Group: 64,914,641 shares worth $1.11B. The largest sale was AbbVie, an estimated $2.98B.
By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 16% a quarter earlier, followed by Financials and Technology.
- Fidelity Investments's largest Q4 2014 buy was UBS Group: 64,914,641 shares worth $1.11B.
- Fidelity Investments added most to Medtronic in Q4 2014, an estimated $1.83B increase.
- Fidelity Investments's biggest Q4 2014 reduction was AbbVie, cutting an estimated $2.98B.
- Fidelity Investments fully exited TIM HORTONS INC COM, CANADA in Q4 2014, selling an estimated $693M.
- Fidelity Investments's ten largest holdings make up 14% of its $769B portfolio in Q4 2014.
- Fidelity Investments opened 176 new positions and closed 160 in Q4 2014.
- Fidelity Investments's portfolio value rose 4.1% quarter-over-quarter to $769B.
Based on Fidelity Investments's 13F filing for Q4 2014, filed 17 Feb 2015.